{"id":"https://openalex.org/W7204709600","doi":"https://doi.org/10.1016/s2152-2650(26)02712-6","title":"IBCL-740: Anchored Matching-Adjusted Indirect Comparison of Epcoritamab, Lenalidomide, and Rituximab vs Tafasitamab, Lenalidomide, and Rituximab in Relapsed/Refractory Follicular Lymphoma: EPCORE FL-1 vs inMIND","display_name":"IBCL-740: Anchored Matching-Adjusted Indirect Comparison of Epcoritamab, Lenalidomide, and Rituximab vs Tafasitamab, Lenalidomide, and Rituximab in Relapsed/Refractory Follicular Lymphoma: EPCORE FL-1 vs inMIND","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204709600","doi":"https://doi.org/10.1016/s2152-2650(26)02712-6"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02712-6","doi":"https://doi.org/10.1016/s2152-2650(26)02712-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02712-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015988282","display_name":"Kim Linton","orcid":"https://orcid.org/0000-0002-3294-1548","observed_orcids":["https://orcid.org/0000-0002-3294-1548"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4392738304","display_name":"Cancer Research UK Manchester Centre","ror":"https://ror.org/033svsm10","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210133995","https://openalex.org/I4392738304"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kim M Linton","raw_affiliation_strings":["The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995","https://openalex.org/I4392738304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036543091","display_name":"Moshe Yair Levy","orcid":"https://orcid.org/0000-0002-2570-6128","observed_orcids":["https://orcid.org/0000-0002-2570-6128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moshe Yair Levy","raw_affiliation_strings":["Texas Oncology\u2013Tyler, US Oncology Research, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology\u2013Tyler, US Oncology Research, Dallas, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037105339","display_name":"Dai Maruyama","orcid":"https://orcid.org/0000-0003-0654-6920","observed_orcids":["https://orcid.org/0000-0003-0654-6920"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Dai Maruyama","raw_affiliation_strings":["Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114231674","display_name":"Abel Costa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102764","display_name":"D\u2019Or Institute for Research and Education","ror":"https://ror.org/01mar7r17","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4210102764"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Abel Costa","raw_affiliation_strings":["D\u2019or Institute for Research and Education (IDOR), Department of Hematology, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u2019or Institute for Research and Education (IDOR), Department of Hematology, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I4210102764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065397032","display_name":"Shane A. Gangatharan","orcid":"https://orcid.org/0000-0003-1022-9899","observed_orcids":["https://orcid.org/0000-0003-1022-9899"]},"institutions":[{"id":"https://openalex.org/I2800728469","display_name":"Fiona Stanley Hospital","ror":"https://ror.org/027p0bm56","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800728469","https://openalex.org/I2800882159","https://openalex.org/I4388446375","https://openalex.org/I4388482742"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shane Gangatharan","raw_affiliation_strings":["Fiona Stanley Hospital, Murdoch, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fiona Stanley Hospital, Murdoch, WA, Australia","institution_ids":["https://openalex.org/I2800728469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024431512","display_name":"Habte Aragaw Yimer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Habte Yimer","raw_affiliation_strings":["Texas Oncology\u2013Tyler, US Oncology Research, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology\u2013Tyler, US Oncology Research, Dallas, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034099180","display_name":"Abualbishr Alshreef","orcid":"https://orcid.org/0000-0003-2737-1365","observed_orcids":["https://orcid.org/0000-0003-2737-1365"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abualbishr Alshreef","raw_affiliation_strings":["AbbVie, Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148733273","display_name":"Wenying Quan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenying Quan","raw_affiliation_strings":["OPEN Health, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OPEN Health, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084341014","display_name":"Viktor Chirikov","orcid":"https://orcid.org/0000-0002-9480-0580","observed_orcids":["https://orcid.org/0000-0002-9480-0580"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viktor Chirikov","raw_affiliation_strings":["OPEN Health, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OPEN Health, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007800019","display_name":"Gauri Sunkersett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gauri Sunkersett","raw_affiliation_strings":["AbbVie, Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106629891","display_name":"JP Mei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JP Mei","raw_affiliation_strings":["AbbVie, Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140257034","display_name":"Anthony Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Wang","raw_affiliation_strings":["AbbVie, Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034210087","display_name":"Savreet Bains Chawla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Savreet Bains Chawla","raw_affiliation_strings":["Genmab, Plainsboro, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Plainsboro, NJ, USA","institution_ids":["https://openalex.org/I266595603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109504304","display_name":"Laura Liao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Liao","raw_affiliation_strings":["Genmab, Plainsboro, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Plainsboro, NJ, USA","institution_ids":["https://openalex.org/I266595603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115008236","display_name":"Felipe Marques Gon\u00e7alves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Felipe Marques Goncalves","raw_affiliation_strings":["Genmab, Plainsboro, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Plainsboro, NJ, USA","institution_ids":["https://openalex.org/I266595603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061242940","display_name":"Zhijie Ding","orcid":"https://orcid.org/0000-0002-4290-4513","observed_orcids":["https://orcid.org/0000-0002-4290-4513"]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhijie Ding","raw_affiliation_strings":["Genmab, Plainsboro, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Plainsboro, NJ, USA","institution_ids":["https://openalex.org/I266595603"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024047541","display_name":"Marcel Nijland","orcid":"https://orcid.org/0000-0002-2740-2873","observed_orcids":["https://orcid.org/0000-0002-2740-2873"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marcel Nijland","raw_affiliation_strings":["University Medical Center Groningen and University of Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Groningen and University of Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.64569514,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S989","last_page":"S990"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epcoritamab","display_name":"epcoritamab","score":0.902999997138977},{"id":"https://openalex.org/keywords/tafasitamab","display_name":"tafasitamab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/relapsed-refractory-follicular-lymphoma","display_name":"relapsed/refractory follicular lymphoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8650000095367432},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.828000009059906},{"id":"https://openalex.org/keywords/complete-response-rate","display_name":"complete response rate","score":0.7540000081062317},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9959999918937683},{"id":"https://openalex.org/keywords/time-to-next-treatment","display_name":"time to next treatment","score":0.9430000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9739000201225281},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9293000102043152},{"id":"https://openalex.org/C187785154","wikidata":"https://www.wikidata.org/wiki/Q5464664","display_name":"Follicular phase","level":2,"score":0.6434999704360962},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6327000260353088},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5785999894142151},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5076000094413757},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29269999265670776},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.24420000612735748},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.23190000653266907},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.23010000586509705}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02712-6","doi":"https://doi.org/10.1016/s2152-2650(26)02712-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02712-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223471468","https://openalex.org/W7204683096","https://openalex.org/W4417016158","https://openalex.org/W4411344793","https://openalex.org/W4417091922","https://openalex.org/W7167705744","https://openalex.org/W4389220942","https://openalex.org/W7113241076","https://openalex.org/W4416746615","https://openalex.org/W7215127743"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2026-08-31T00:00:00"}